Regulatory Aspects of the Development of Drugs for Metabolic Bone Diseases – FDA and EMA Perspective
British Journal of Clinical Pharmacology,Volume 0, Issue ja, -Not available-.
Source: British Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Authors: Theresa Kehoe,
Eberhard Blind,
Heidi Janssen Source Type: research